EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pharmacologic Options for Treatment and Prevention of Hypertensive Disorders of Pregnancy

E Nicole Teal, Isabel Katlaps, Jerome Yankowitz

Clinics in Perinatology · 2026-09 · 53 (3) · 465-480

DOI: 10.1016/j.clp.2026.04.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinics in Perinatology, 2026-09. Verfasst von E Nicole Teal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Diego. Electronic ad…. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension, Pregnancy-Induced. Die Arbeit nennt 82 Literaturangaben. Gefördert von: National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertensive disorders affect 15% of US pregnancies, significantly contributing to maternal and neonatal morbidity. This paper explores the profound hemodynamic adaptations of pregnancy and how their failure leads to conditions like preeclampsia and gestational hypertension. Diagnosis relies on blood pressure thresholds (≥140/90 mm Hg), with management focusing on preventing severe sequelae. Labetalol and nifedipine are established as first-line treatments due to their safety and efficacy, while angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are strictly contraindicated due to fetotoxicity. Low-dose aspirin is recommended for high-risk patients. Ultimately, early recognition and evidence-based pharmacologic intervention are critical for improving obstetric outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsHypertension, Pregnancy-InducedHumansPregnancyFemaleAngiotensin-Converting Enzyme InhibitorsNifedipineLabetalolAspirinAngiotensin Receptor AntagonistsCalcium Channel BlockersPre-EclampsiaPlatelet Aggregation Inhibitors

Stichwörter der Autor:innen

Antihypertensive medicationsHypertension managementHypertensive disorders of pregnancyMedication safetyPregnancy

Substanzen

Antihypertensive AgentsAngiotensin-Converting Enzyme InhibitorsNifedipineLabetalolAspirinAngiotensin Receptor AntagonistsCalcium Channel BlockersPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Diego. Electronic address: enteal@health.ucsd.edu.
  • Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Diego.
  • Department of Obstetrics and Gynecology, University of Iowa and University of South Florida.

Förderung

  • National Institutes of Health

Zitieren

APA

Teal, E. N., Katlaps, I., & Yankowitz, J. (2026). Pharmacologic Options for Treatment and Prevention of Hypertensive Disorders of Pregnancy. Clinics in Perinatology, 53(3), 465-480. https://doi.org/10.1016/j.clp.2026.04.002

Vancouver

Teal EN, Katlaps I, Yankowitz J. Pharmacologic Options for Treatment and Prevention of Hypertensive Disorders of Pregnancy. Clinics in Perinatology. 2026;53(3):465-480. doi:10.1016/j.clp.2026.04.002

BibTeX
@article{Teal2026,
  author = {Teal, E Nicole and Katlaps, Isabel and Yankowitz, Jerome},
  title = {Pharmacologic Options for Treatment and Prevention of Hypertensive Disorders of Pregnancy},
  journal = {Clinics in Perinatology},
  year = {2026},
  volume = {53},
  number = {3},
  pages = {465--480},
  doi = {10.1016/j.clp.2026.04.002}
}
Kostenlos starten →